SPRING BANK PHARMACEUTICALS (SBPH) earnings
Quarterly and annual SBPH reports and results, each read against the price at its own news timestamp. Back to the SBPH overview →
No SBPH earnings events in the measured window.
Nothing matched in the current window — the SBPH overview has every event we measure for this name.
Get an email when SBPH moves on news →Keep exploring
More SBPH: analyst actions → · SEC filings → · SBPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NeoGenomics, Inc. (NEO) | 406 | -0.22% | 44% |
| Vericel Corporation (VCEL) | 406 | -0.19% | 40% |
| AKCEA THERAPEUTICS (AKCA) | 401 | 0.00% | 49% |
| Blueprint Medicines Corporation (BPMC) | 401 | -0.03% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.